Safety/Biomarker Study of CNTO 95 and Avastin in Solid Tumors
Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to find out what side effects the combination of the
two study drugs, bevacizumab (Avastin) and CNTO 95 have on the body and to determine the
highest dose of CNTO 95 that can be given with bevacizumab that is safe and well tolerated.